Loïc Ysebaert
0000-0001-8478-5623
6 papers found
Refreshing results…
Clinical and biological characteristics of leukemia cutis in chronic lymphocytic leukemia: A study of the French innovative leukemia organization (FILO)
Ibrutinib and idelalisib in the management of CLL‐associated autoimmune cytopenias: a study from the FILO group
Efficacy of chemotherapy or chemo-anti-PD-1 combination after failed anti-PD-1 therapy for relapsed and refractory hodgkin lymphoma: A series from lysa centers
Bendamustine plus rituximab for indolent B-cell lymphoma of renal significance
Outcome of chronic lymphocytic leukemia patients who switched from either ibrutinib or idelalisib to alternate kinase inhibitor: A retrospective study of the French innovative leukemia organization (FILO)
Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real‐world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group
Missing publications? Search for publications with a matching author name.